Most Read Articles
Rachel Soon, 12 Dec 2018

MIMS Pharmacist speaks to Cpt. Manvikram Singh Gill, military pharmacist with the Royal Medical and Dental Corps (RMDC) of the Malaysian Armed Forces (MAF),about his work at the Rohingya refugee camp in Cox's Bazar, Bangladesh.

Ms Penny Wong Pei Nee, 12 Jul 2018
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.
Elaine Soliven, 30 Jun 2020
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
Jairia Dela Cruz, 20 May 2020
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.

Long- and short-term SSRI use contributes to increased hip fracture risk

07 Nov 2019

Treatment with selective serotonin reuptake inhibitors (SSRIs) in the short and long term appears to bear an increased risk of hip fracture, according to a recent study.

The case-control study used data from the US Renal Data System and included 4,912 maintenance haemodialysis patients with hip fracture and 49,120 nonfracture controls. All participants had >1 year of Medicare parts A and B coverage and >3 years of part D coverage.

During the 3-year part D coverage period, SSRI exposure was characterized as any (≥1 prescription filled), low, moderate and high use (<20 percent, 20 to <80 percent, and ≥80 percent of days covered by filled prescriptions, respectively).

On conditional logistic regression analysis, SSRI use conferred a 25-percent increase in hip fracture risk (adjusted odds ratio [OR], 1.25, 95 percent confidence interval [CI], 1.17–1.35). Risk estimates for fracture associated with any, low, moderate and high SSRI use were as follows: 1.25 (95 percent CI, 1.17–1.35), 1.20 (95 percent CI, 1.08–1.32), 1.31 (95 percent CI, 1.18–1.43) and 1.26 (95 percent CI, 1.12–1.41), respectively.

Researchers performed a separate examination of new short-term SSRI exposure in cases and controls with >18 months of part D coverage and no prior antidepressant use for 1 year. Results revealed a similar pattern of association with hip fracture risk (adjusted OR, 1.43, 95 percent CI, 1.23–1.67).

“The stronger association with new short-term use may suggest an acute mechanism potentially related to falls,” the researchers explained.

The study was limited by the inability to capture and account for biomarkers of mineral bone disorder.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Pharmacist - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Rachel Soon, 12 Dec 2018

MIMS Pharmacist speaks to Cpt. Manvikram Singh Gill, military pharmacist with the Royal Medical and Dental Corps (RMDC) of the Malaysian Armed Forces (MAF),about his work at the Rohingya refugee camp in Cox's Bazar, Bangladesh.

Ms Penny Wong Pei Nee, 12 Jul 2018
Antibiotics, also known as antibacterials, are a group of medications that either destroy the infecting bacteria or slow down their growth.
Elaine Soliven, 30 Jun 2020
Treatment with Lactobacillus crispatus CTV-05 (Lactin-V) significantly reduces the incidence of bacterial vaginosis recurrence in women who were previously treated with vaginal metronidazole, according to a recent study.
Jairia Dela Cruz, 20 May 2020
Concomitant use of fimasartan and rosuvastatin in patients with hypertension and dyslipidaemia does not appear to be synergistic in increasing concurrent control rate of the diseases, although either drug is effective against the target disease, according to a study.